Dynavax Technologies (DVAX) 15.96 $DVAX Dynavax Presents

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Dynavax Technologies (DVAX) 15.96 $DVAX

Dynavax Presents New Efficacy Data on Hepatitis B Vaccine, HEPLISAV-B(TM), in Adults With Type 2 Diabetes at ADA Scientific Sessions
Marketwired - Sat Jun 11, 10:00AM CDT
Pivotal Phase 3 Data Show Investigational Two-Dose Hepatitis B Vaccine Provides a Significantly Higher Rate of Seroprotection Than an Approved Vaccine in Patients With Type 2 Diabetes
DVAX: 15.96 (+0.53)

Coverage of Biotechnology Equities - Pacific Biosciences of California, Peregrine Pharma, Dynavax Technologies and Anavex Life Sciences
PR Newswire - Fri Jun 10, 6:45AM CDT
On Thursday, June 09, 2016, the NASDAQ Composite ended the trading session at 4,958.62, down 0.32%; the Dow Jones Industrial Average edged 0.11% lower to finish at 17,985.19; and the S&P 500 closed at 2,115.48, down 0.17%. ActiveWallSt.com has initiated coverage on the following equities: Pacific Biosciences of California Inc. (NASDAQ: PACB), Peregrine Pharmaceuticals Inc. (NASDAQ: PPHM), Dynavax Technologies Corporation (NASDAQ: DVAX), and Anavex Life Sciences Corporation (NASDAQ: AVXL). Learn more about these stocks by accessing their free trade alerts at:
DVAX: 15.96 (+0.53), PACB: 8.62 (+0.07), AVXL: 3.61 (-0.23), PPHM: 0.37 (unch)

Dynavax to Present at Two Upcoming Investor Conferences
Marketwired - Wed May 18, 6:01AM CDT
BERKELEY, CA--(Marketwired - May 18, 2016) - Dynavax Technologies Corporation (NASDAQ: DVAX) today announced that it will present at two upcoming investor conferences. Information relating to the two presentations follows:
DVAX: 15.96 (+0.53)

Dynavax Technologies Down 16.5% Since SmarTrend Downtrend Call (DVAX)
Comtex SmarTrend(R) - Fri May 13, 1:38PM CDT
SmarTrend identified a Downtrend for Dynavax Technologies (NASDAQVAX) on April 27th, 2016 at $18.36. In approximately 2 weeks, Dynavax Technologies has returned 16.54% as of today's recent price of $15.32.
DVAX: 15.96 (+0.53)

Dynavax Technologies reports 1Q loss
Automated Insights - Mon May 09, 8:05AM CDT
BERKELEY, Calif. (AP) _ Dynavax Technologies Corp. (DVAX) on Monday reported a loss of $27 million in its first quarter.
DVAX: 15.96 (+0.53)

Dynavax Reports First Quarter 2016 Financial Results
Marketwire Canada - Mon May 09, 8:02AM CDT
BERKELEY, CA--(Marketwired - May 09, 2016) - Dynavax Technologies Corporation (NASDAQ: DVAX) today reported financial results for the first quarter ended March 31, 2016.
DVAX: 15.96 (+0.53)

Does This Upstart Pose a Threat to GlaxoSmithKline?
Todd Campbell, The Motley Fool - Motley Fool - Tue May 03, 7:40AM CDT
SOURCE: GLAXOSMITHKLINE PLC. GlaxoSmithKline plc generates more than $1.2 billion per quarter selling vaccines that are used to treat infectious disease, and one of GlaxoSmithKline's top-selling vaccines is Engerix-B, a vaccine used to prevent...
DVAX: 15.96 (+0.53), GSK: 45.25 (+0.18)

Downgrade Alert for Dynavax Technologies (DVAX)
Comtex SmarTrend(R) - Fri Apr 29, 4:01AM CDT
Dynavax Technologies (NASDAQVAX) was downgraded from Outperform to Sector Perform at RBC Capital today. The stock closed yesterday at $17.53 on volume of 1.1 million shares, above average daily volume of 901,000. Dynavax Technologies Corporation discovers, develops, and is seeking to commercialize products based on immunostimulatory sequences. The Company is developing products to treat and prevent allergies, infectious diseases, and chronic inflammatory diseases using approaches that alter immune system responses in specific ways.
DVAX: 15.96 (+0.53)

Why Dynavex Technologies Shares Are Crashing Today
Todd Campbell, The Motley Fool - Motley Fool - Wed Apr 27, 1:04PM CDT
SOURCE: DYNAVEX TECHNOLOGIES What:  After the FDA said it needs more time to review its application for approval of HEPLISAV-B, shares of Dynavex Technologies Corp. are tumbling, down 12.6% at 1:00 p.m Wednesday. So what: The FDA is...
DVAX: 15.96 (+0.53)

Dynavax Receives Notification of PDUFA Extension for HEPLISAV-B to December 15, 2016
Marketwired - Wed Apr 27, 6:01AM CDT
Dynavax Technologies Corporation (NASDAQ: DVAX) today announced that the U.S. Food and Drug Administration (FDA) will require additional time to complete its review of the Biologics License Application (BLA) for HEPLISAV-B(TM), Dynavax's investigational vaccine for immunization of adults against hepatitis B infection. In a notice received from the FDA, the Prescription Drug User Fee Act (PDUFA) action date for HEPLISAV-B has been extended by three months to December 15, 2016.
DVAX: 15.96 (+0.53)

3 Biotech Stocks I'd Buy Right Now
Keith Speights, The Motley Fool - Motley Fool - Thu Apr 21, 9:43AM CDT
Image Source: Celgene In case you haven't noticed, biotech stocks are finally on a roll again. After months of sliding downward, many are now mounting comebacks. While not every biotech stock is a winner, there are plenty of great picks. Here are...
DVAX: 15.96 (+0.53), JUNO: 30.86 (-0.07), CELG: 114.69 (+2.50)

Dynavax Presents Encouraging Data From Clinical Trial of Immuno-Oncology Product Candidate, SD-101
Marketwired - Mon Apr 18, 3:02PM CDT
Dynavax Technologies Corporation (NASDAQ: DVAX) today announced encouraging additional data from Part 1 of a Phase 1/2 study (LYM-01) evaluating the company's lead immunotherapy product candidate, SD-101, in combination with low-dose radiation in lymphoma patients. The data were presented at the American Association for Cancer Research (AACR) Annual Meeting in New Orleans, Louisiana.
DVAX: 15.96 (+0.53)

Dynavax Presents Pivotal Phase 3 Data Showing HEPLISAV-B(TM) Provides Significantly Higher Protection Against Hepatitis B Than Engerix-B(R)
Marketwired - Mon Apr 18, 3:02PM CDT
Dynavax Technologies Corporation (NASDAQ: DVAX) today announced results from HBV-23, a pivotal Phase 3 trial that provides head-to-head safety and immunogenicity data comparing its investigational adult hepatitis B vaccine, HEPLISAV-B, with the leading vaccine, Engerix-B, in adults 18 to 70 years of age. These data were presented at the National Foundation for Infectious Diseases' (NFID) 19th Annual Conference on Vaccine Research (ACVR) in Baltimore, MD.
DVAX: 15.96 (+0.53)

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Nauticus Robotics Dive into Defense & UAE Moves

Updated Category News Views 211

Charting New Waters: Defense and UAE Focus Looking at Nauticus Robotics lately, it feels like they're finally getting the hang of balancing their defense play and UAE expansions. This quarter they're coming out swinging, dropping some fine numbers mixed with a slew of strategic moves that got me thinking twice about their place in the subsea robotics world. Financial...

Continue Reading
NeuroPace Faces Investigation After Revenue Forecast Cut

Updated Category News Views 35

NeuroPace Revenue Drama: A Blow to Investor Confidence How the mighty have stumbled—or so it feels to the folks who put their bucks into NeuroPace, Inc. (NASDAQ: NPCE). It's tough to swallow: they cut their 2026 revenue forecast from a hopeful $99.5-$101.5 million to a sobering $91-$92 million. Just one quarter apart those projections are, like a cruel twist of fate...

Continue Reading
Choate's Expands to New Mid-South Markets

Updated Category News Views 155

Family Traditions Drive Choate's Growth Back in the day, you might've thought the family-run businesses were a dying breed, right? Not in the case of Choate's Air Conditioning, Heating, Plumbing & Electrical. These folks aren't just holding the fort; they're storming new territories across the Mid-South like they've got something to prove—or maybe just something to...

Continue Reading
AppLovin Faces Legal Heat: Investors on Edge Today

Updated Category News Views 104

AppLovin's Day of Reckoning: Investors Take Note Ever find yourself caught in a whirlwind of corporate promises that slide into disappointment? Well, buckle up, because that's exactly where AppLovin finds itself today. They've stirred up a storm with investors over some questionable hyperbole about their artificial intelligence tools and ad services. Missteps and Market...

Continue Reading
equipifi's BNPL Shop: New Ammo for Credit Unions

Updated Category News Views 189

equipifi's 'Shop': The Big Play in Banking Look, here’s the deal—equipifi just lobbed a new grenade into the finance battlefield, arming credit unions and community banks with 'Shop', their own Buy Now, Pay Later (BNPL) platform. The goal? To put them toe-to-toe with the big fintech wolves—something these smaller guys desperately needed. It's a meaty move, no...

Continue Reading
Tigo Energy Faces Lawsuit: Key Details for Investors

Updated Category News Views 123

Tigo Energy Inc.'s Troubles: A Stock Drop and Legal Woes You see, not every day do you wake up to find your investment taking a nose dive by 36.76%. But that’s exactly what happened to Tigo Energy, Inc. (NASDAQ: TYGO) after some shaky announcements. A Rollercoaster for Investors On August 4, 2026, Tigo hit investors with a one-two punch: revised financial outlook and...

Continue Reading
Texxon Faces Revenue Slide Amid Strategic Shifts

Updated Category News Views 68

Texxon's Strategic Transitions and Financial Headaches Texxon Holding Limited (NASDAQ:NPT) just laid their cards on the table, unveiling a mixed bag in their fiscal year 2026 results. As the world's chemical and plastics scene faces winds of change, Texxon buckled down and tried to steer the ship clear from the rocks. It's a balancing act juggling market headwinds, a new...

Continue Reading
Operation Healing Forces Partners with Wounded Warrior

Updated Category News Views 56

Joining Forces for Special Operations Families When it comes to the heavy lifting of supporting Special Operations Forces (SOF) families, two powerhouses—Operation Healing Forces (OHF) and Wounded Warrior Project (WWP)—are doubling down. They’re not just tossing around good intentions. Oh no, they’re pulling out the stops with a solid partnership focused on...

Continue Reading
Duolingo Faces Class Action: Key Investor Steps

Updated Category News Views 126

Navigating Turbulent Times with Duolingo Holy moly, the dumpster fire that is the Duolingo (NASDAQ:DUOL) legal saga just got hotter. If you snagged yourself some shares between May 2, 2025, and February 26, 2026, you'd better sit down and grab some antacids—because the nauseating roller coaster is far from over. Robbins LLP is rounding up the troops for a class action,...

Continue Reading
SiteOne Joins S&P SmallCap 600 Amid KKR's Integer Buyout

Updated Category News Views 142

Changes on the SmallCap Horizon Starting off, SiteOne Landscape Supply (NYSE: SITE) is hopping onto the S&P SmallCap 600 bandwagon. This shift activates just as the market revs up on November 19, 2026. SiteOne is stepping in as Integer Holdings Corp. (NYSE: ITGR) makes its grand exit, a move prompted by a significant acquisition by KKR & Co. Inc. (NYSE: KKR). KKR’s...

Continue Reading

Top 5 Most Recently Viewed Articles

Experience the Art of Taiko Drumming at Asano Taiko Factory Tour

Updated Category News Views 142

Step into the World of Taiko Drumming at Asano Have you ever experienced the powerful beats of a taiko drum? Located in Japan, Asano Taiko offers an immersive journey into the fascinating world of taiko drumming. With over 400 years of tradition behind them, Asano Taiko is renowned for its craftsmanship, making it one of the leading manufacturers of traditional Japanese...

Continue Reading
Critical Foot Care Initiative by Forté Orthopedic and Colts

Updated Category News Views 193

Critical Support for Foot Health Needs In the heart of Indiana, a remarkable initiative is transforming the lives of those in need. Forté Orthopedic Research Institute has joined forces with the Indianapolis Colts to create an event called Hearts 2 Soles. This annual event is dedicated to improving foot health among the unhoused community. People facing homelessness...

Continue Reading
Options Activity Sparks Interest in First Majestic Silver

Updated Category News Views 212

Investors Show Strong Interest in First Majestic Silver Recent developments in the options market indicate that investors are making significant bets on First Majestic Silver (NYSE: AG). This heightened activity could be a sign of underlying trends that investors should monitor closely. What We See in the Options Market The surge in options trading for AG has caught the...

Continue Reading
Projected Surge in Enterprise GenAI Spending for 2025

Updated Category News Views 174

The Future of Enterprise Investment in GenAI Enterprises are looking forward to a significant return on investment (ROI) from generative AI (GenAI) projects by 2025. Expectations predict a 50% increase in spending, as companies shift their priorities from simply boosting efficiency to enriching human expertise with advanced technologies. Key Findings from Recent Research...

Continue Reading
Liquidity Services Expands with Auction Software Purchase

Updated Category News Views 226

Liquidity Services Enhances Its Software Offerings Liquidity Services, Inc. (NASDAQ:LQDT), a prominent player in the global commerce sector, has recently made headlines with its acquisition of Auction Software, a recognized leader in auction and marketplace technology. This step is outlined as a strategic move to boost Liquidity Services’ capabilities in the Circular...

Continue Reading